News > Cambrex to invest $16.5 Million in new R&D facility in Minneapolis, Minnesota and expansion in Charles City, Iowa

Cambrex to invest $16.5 Million in new R&D facility in Minneapolis, Minnesota and expansion in Charles City, Iowa

Dkoding | 27/10/2022 04:56 PM | Click to read full article

Strategically located near the Minneapolis–St. Paul Airport, the new facility will specialize in analytical and chemical development for pharmaceutical drug candidates and will operate as an extension of Cambrex’s flagship facility in Charles City, Iowa. Cambrex will simultaneously launch a multi-phase, 9,000-square-foot expansion and 21,000-square-foot renovation project in Charles City

 

-